BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36203762)

  • 1. Nail changes in pemphigus and bullous pemphigoid: A single-center study in China.
    Cao S; Cui X; Li J; Pan F; Yan X; Yang Q; Chen M; Zhou S; Du D; Wang W; Sun Y; Shi Z; Wu M; Yang B; Zhang F
    Front Med (Lausanne); 2022; 9():933608. PubMed ID: 36203762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.
    Raap U; Limberg MM; Kridin K; Ludwig RJ
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases.
    Heckler I; Hong M; Amart Sinha A; Venkataraman I
    Dermatol Pract Concept; 2022 May; 12(2):e2022116. PubMed ID: 35646449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting.
    Oyama N; Bhogal BS; Carrington P; Gratian MJ; Black MM
    Br J Dermatol; 2003 May; 148(5):939-44. PubMed ID: 12786824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
    Zhang JL; Wang SH; Cui SN; Zhang J; Li SZ; Li L; Zuo YG
    J Dermatol; 2023 Nov; 50(11):1433-1441. PubMed ID: 37501390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nail changes in pemphigus: a systematic review and meta-analysis.
    Ng CX; Lau Xer Min N; Choi EC; Long V; Chandran NS
    Int J Dermatol; 2024 Jun; ():. PubMed ID: 38887088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of six autoimmune bullous diseases with thyroid disorders: a population-based study.
    Kridin K; Hübner F; Linder R; Schmidt E
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1826-1830. PubMed ID: 35611551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune bullous skin diseases].
    Joly P
    Rev Med Interne; 1999 Jan; 20(1):26-38. PubMed ID: 10220817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus disease activity measurements: pemphigus disease area index, autoimmune bullous skin disorder intensity score, and pemphigus vulgaris activity score.
    Rahbar Z; Daneshpazhooh M; Mirshams-Shahshahani M; Esmaili N; Heidari K; Aghazadeh N; Hejazi P; Ghajarzadeh M; Chams-Davatchi C
    JAMA Dermatol; 2014 Mar; 150(3):266-72. PubMed ID: 24429657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modern diagnostics of autoimmune bullous diseases].
    van Beek N; Schumacher N; Rose C; Schmidt E; Zillikens D
    Pathologe; 2020 Jul; 41(4):317-325. PubMed ID: 32542511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study.
    Xie D; Bilgic A; Abu Alrub N; Dicle Ö; Murrell DF
    JAAD Int; 2023 Mar; 10():6-13. PubMed ID: 36387063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin-Related Quality of Life During Autoimmune Bullous Disease Course.
    Hopkins ZH; Jimenez A; Taliercio VL; Clarke JT; Hansen CB; Hull CM; Rhoads JLW; Zone JJ; Sahni VN; Kean J; Secrest AM
    JAMA Dermatol; 2023 Nov; 159(11):1185-1194. PubMed ID: 37703003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Autoimmune Blistering Disease: A Systematic Review.
    Zhao CY; Chiang YZ; Murrell DF
    Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogeneses of pemphigus and pemphigoid diseases.
    Ujiie H; Yamagami J; Takahashi H; Izumi K; Iwata H; Wang G; Sawamura D; Amagai M; Zillikens D
    J Dermatol Sci; 2021 Dec; 104(3):154-163. PubMed ID: 34916040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study.
    Marzano AV; Trevisan V; Cairoli E; Eller-Vainicher C; Morelli V; Spada A; Crosti C; Chiodini I
    Orphanet J Rare Dis; 2015 Feb; 10():8. PubMed ID: 25644263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Monocentric Retrospective Observational Study of Comorbidities in Patients Affected by Autoimmune Bullous Diseases.
    Ferranti M; Gobbo G; Cicogna GT; Alaibac M
    In Vivo; 2020; 34(4):2113-2118. PubMed ID: 32606191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent in situ expression of IL-31 and IL-31RA between bullous pemphigoid and pemphigus vulgaris.
    Ergun EZ; Aoki R; Horváth ON; Hartmann D; Satoh TK; Calabrese L; Aksu AEK; Gürel MS; Manav V; Flaig MJ; Sárdy M; Ruzicka T; French LE; Bağcı IS
    Exp Dermatol; 2023 Sep; 32(9):1412-1419. PubMed ID: 37260420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gut microbiota dysbiosis between pemphigus vulgaris and bullous pemphigoid.
    Han Z; Fan Y; Wu Q; Guo F; Li S; Hu X; Zuo YG
    Int Immunopharmacol; 2024 Feb; 128():111470. PubMed ID: 38185033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.